Recruiting at 1 site No phase Childhood Asthma

Childhood Asthma study: EPA-AQI vs Commerical-AQI

Official title Pollution Intervention to Impact Kids Asthma Study

ClinicalTrials.gov ID: NCT07261423

What this study is testing

What it's testing
This study is testing whether including air‑quality data in asthma action plans improves asthma outcomes in children. It also looks at how sensitive kids feel to outdoor air pollution.
Who it's for
You may be able to join if you are a child with asthma and you or your parents can follow the study plan.
What's involved
You will get a simple asthma action plan that shows air‑quality levels. You will learn about outdoor air pollution. You will give a nose sample and a blood sample. You will have phone check‑ins and a few in‑person visits.
Time commitment
The study lasts 48 weeks. You will have visits every 4 weeks, with 10 phone calls and 3 in‑person visits.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 8 to 17

You may be able to join if

  • A healthcare provider diagnosis of persistent asthma (Steps 2-5 as defined by US guidelines) or intermittent asthma (Step 1) + at least one severe...
  • Home access to a smartphone or internet
  • Primary residence in Allegheny County, PA
  • One participant per household
  • Age 8 -17 years

You likely can't join if

  • Diagnosis of other active chronic respiratory diseases (e.g., cystic fibrosis, bronchopulmonary dysplasia, etc.)
  • Neuromuscular disorder
  • Chronic disorder limiting independent ambulation (e.g., spastic quadriplegia, etc.)
  • Cyanotic heart disease
  • Plans to relocate from Allegheny County, PA in the next year (12 months)
  • Use of intranasal or oral/intramuscular/intravenous corticosteroids 4 weeks prior to randomization
See the full eligibility criteria
Who can join
  • A healthcare provider diagnosis of persistent asthma (Steps 2-5 as defined by US guidelines) or intermittent asthma (Step 1) + at least one severe asthma exacerbation (defined by American Thoracic Society (ATS)/European...
  • Home access to a smartphone or internet
  • Primary residence in Allegheny County, PA
  • One participant per household
  • Age 8 -17 years
  • Healthcare provider evaluation for asthma in the prior year
What rules you out
  • Diagnosis of other active chronic respiratory diseases (e.g., cystic fibrosis, bronchopulmonary dysplasia, etc.)
  • Neuromuscular disorder
  • Chronic disorder limiting independent ambulation (e.g., spastic quadriplegia, etc.)
  • Cyanotic heart disease
  • Plans to relocate from Allegheny County, PA in the next year (12 months)
  • Use of intranasal or oral/intramuscular/intravenous corticosteroids 4 weeks prior to randomization
  • Current participation in another asthma intervention trial

The study team makes the final eligibility decision.

Where it is enrolling

  • Pittsburgh, Pennsylvania, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 8 years to 17 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.